Showing 1 - 10 results of 10 for search 'Katia J Bruxvoort', query time: 0.05s Refine Results
  1. 1
    Risk Factors for Not Completing a 2-Dose Primary Series of Messenger RNA COVID-19 Vaccination in a Large Health Care System in Southern California: Retrospective Cohort Study

    Risk Factors for Not Completing a 2-Dose Primary Series of Messenger RNA COVID-19 Vaccination in a Large Health Care System in Southern California: Retrospective Cohort Study by Stanley Xu, Vennis Hong, Lina S Sy, Katia J Bruxvoort, Bruno Lewin, Bing Han, Kimberly J Holmquist, Lei Qian

    Published 2023-10-01
    Get full text
    Article
  2. 2
    Risk of subsequent lower respiratory tract infection (LRTI) after hospitalization for COVID-19 LRTI and non-COVID-19 LRTI: a retrospective cohort study

    Risk of subsequent lower respiratory tract infection (LRTI) after hospitalization for COVID-19 LRTI and non-COVID-19 LRTI: a retrospective cohort study by Katia J. Bruxvoort, Heidi Fischer, Joseph A. Lewnard, Vennis X. Hong, Magdalena Pomichowski, Lindsay R. Grant, Luis Jódar, Bradford D. Gessner, Sara Y. Tartof

    Published 2023-10-01
    Get full text
    Article
  3. 3
    Real-world effectiveness of the mRNA-1273 vaccine against COVID-19: Interim results from a prospective observational cohort study

    Real-world effectiveness of the mRNA-1273 vaccine against COVID-19: Interim results from a prospective observational cohort study by Katia J. Bruxvoort, Lina S. Sy, Lei Qian, Bradley K. Ackerson, Yi Luo, Gina S. Lee, Yun Tian, Ana Florea, Harpreet S. Takhar, Julia E. Tubert, Carla A. Talarico, Hung Fu Tseng

    Published 2022-02-01
    Get full text
    Article
  4. 4
    Development and validation of a prediction algorithm to identify birth in countries with high tuberculosis incidence in two large California health systems.

    Development and validation of a prediction algorithm to identify birth in countries with high tuberculosis incidence in two large California health systems. by Heidi Fischer, Lei Qian, Jacek Skarbinski, Katia J Bruxvoort, Rong Wei, Kris Li, Laura B Amsden, Mariah S Wood, Abigail Eaton, Brigitte C Spence, Sally F Shaw, Sara Y Tartof

    Published 2022-01-01
    Get full text
    Article
  5. 5
    Durability of mRNA-1273 against COVID-19 in the time of Delta: Interim results from an observational cohort study.

    Durability of mRNA-1273 against COVID-19 in the time of Delta: Interim results from an observational cohort study. by Ana Florea, Lina S Sy, Yi Luo, Lei Qian, Katia J Bruxvoort, Bradley K Ackerson, Gina S Lee, Jennifer H Ku, Julia E Tubert, Yun Tian, Carla A Talarico, Hung Fu Tseng

    Published 2022-01-01
    Get full text
    Article
  6. 6
    Patients with positive malaria tests not given artemisinin-based combination therapies: a research synthesis describing under-prescription of antimalarial medicines in Africa

    Patients with positive malaria tests not given artemisinin-based combination therapies: a research synthesis describing under-prescription of antimalarial medicines in Africa by Shennae O’Boyle, Katia J. Bruxvoort, Evelyn K. Ansah, Helen E. D. Burchett, Clare I. R. Chandler, Siân E. Clarke, Catherine Goodman, Wilfred Mbacham, Anthony K. Mbonye, Obinna E. Onwujekwe, Sarah G. Staedke, Virginia L. Wiseman, Christopher J. M. Whitty, Heidi Hopkins

    Published 2020-01-01
    Get full text
    Article
  7. 7
    Effectiveness of mRNA-1273 vaccination against SARS-CoV-2 omicron subvariants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5

    Effectiveness of mRNA-1273 vaccination against SARS-CoV-2 omicron subvariants BA.1, BA.2, BA.2.12.1, BA.4, and BA.5 by Hung Fu Tseng, Bradley K. Ackerson, Katia J. Bruxvoort, Lina S. Sy, Julia E. Tubert, Gina S. Lee, Jennifer H. Ku, Ana Florea, Yi Luo, Sijia Qiu, Soon Kyu Choi, Harpreet S. Takhar, Michael Aragones, Yamuna D. Paila, Scott Chavers, Carla A. Talarico, Lei Qian

    Published 2023-01-01
    Get full text
    Article
  8. 8
    Impact of California’s Senate Bill 27 on Antimicrobial-Resistant Escherichia coli Urinary Tract Infection in Humans: Protocol for a Study of Methods and Baseline Data

    Impact of California’s Senate Bill 27 on Antimicrobial-Resistant Escherichia coli Urinary Tract Infection in Humans: Protocol for a Study of Methods and Baseline Data by Ana Florea, Joan A Casey, Keeve Nachman, Lance B Price, Magdalena E Pomichowski, Harpreet S Takhar, Vanessa Quinlivan, Lee D Childs, Meghan F Davis, Rong Wei, Vennis Hong, Jennifer H Ku, Cindy M Liu, Alice Pressman, Sarah Robinson, Katia J Bruxvoort, S Bianca Salas, Sara Y Tartof

    Published 2023-05-01
    Get full text
    Article
  9. 9
    mRNA-1273 bivalent (original and Omicron) COVID-19 vaccine effectiveness against COVID-19 outcomes in the United States

    mRNA-1273 bivalent (original and Omicron) COVID-19 vaccine effectiveness against COVID-19 outcomes in the United States by Hung Fu Tseng, Bradley K. Ackerson, Lina S. Sy, Julia E. Tubert, Yi Luo, Sijia Qiu, Gina S. Lee, Katia J. Bruxvoort, Jennifer H. Ku, Ana Florea, Harpreet S. Takhar, Radha Bathala, Cindy Ke Zhou, Daina B. Esposito, Morgan A. Marks, Evan J. Anderson, Carla A. Talarico, Lei Qian

    Published 2023-09-01
    Get full text
    Article
  10. 10
    Effectiveness and durability of mRNA-1273 BA.4/BA.5 bivalent vaccine (mRNA-1273.222) against SARS-CoV-2 BA.4/BA.5 and XBB sublineages

    Effectiveness and durability of mRNA-1273 BA.4/BA.5 bivalent vaccine (mRNA-1273.222) against SARS-CoV-2 BA.4/BA.5 and XBB sublineages by Bradley K. Ackerson, Katia J. Bruxvoort, Lei Qian, Lina S. Sy, Sijia Qiu, Julia E. Tubert, Gina S. Lee, Jennifer H. Ku, Ana Florea, Yi Luo, Radha Bathala, Julie Stern, Soon K. Choi, Harpreet S. Takhar, Michael Aragones, Morgan A. Marks, Evan J. Anderson, Cindy Ke Zhou, Tianyu Sun, Carla A. Talarico, Hung Fu Tseng

    Published 2024-12-01
    Get full text
    Article

Search Tools: